Golden
Anviro Therapeutics

Anviro Therapeutics

Anviro Therapeutics is a biotechnology company developing broad spectrum antiviral therapies.

Anviro Therapeutics is a privately held, biotechnology company making broad-spectrum antiviral therapeutics that is based in Orem, Utah and was founded in 2015 by Kyle Lane and Matthew Cryer. The company is developing treatments for several infectious diseases, including pox viruses and herpes viruses. Their lead program is based on technology discovered by researchers at Brigham Young University (BYU).

The compound, designated KPB-100, has antiviral properties across a range of viruses in the herpes and pox virus families. KPB-100 is a small molecule that utilizes a mechanism of action directed at morphogenesis inhibition, which allows it to be used as a treatment against strains of the herpes virus that are resistant to frontline treatments.

In vitro and in vivo assays have shown potential for KPB-100 as a topical treatment for several DNA-viruses, including:

  • Wildtype and mutant HSV-1 and HSV-2
  • Herpes zoster (shingles)
  • Progressive vaccinia
  • Adverse effects of smallpox vaccination

Anviro's expected timeline for the product is as follows:

  • 2018 - Submission of Investigational New Drug (IND) Application to the USFDA
  • 2018 - 2019 - Small Scale Clinical Trial (Phase 1)
  • 2020 - 2023 - Large Scale Clinical Trial (Phase 2)
  • 2023 - 2025 - Comparative Clinical Trial (Phase 3)
  • 2026 - Commercial Launch

Funding

Seed

On January 1, 2016 Anviro Therapeutics completed their seed funding round with $650,000 in funding from undisclosed investors.

Timeline

2016

Seed funding

On January 1, 2016 Anviro Therapeutics completed their seed funding round with $650,000 in funding from undisclosed investors.

March 28, 2015

Founding of Anviro Therapeutics

Anviro Therapeutics was founded in 2015 by Kyle Lane and Matthew Cryer.

2015

Anviro Therapeutics was founded by Matthew Cryer and Kyle Lane.

People

Name
Role
LinkedIn

Alonzo Cook

Employee

Kyle Lane

COO

Marc Hansen

Acting Chief Scientific Officer

Mark Elder

CFO

Matthew Cryer

Founder & CEO

Merritt Andrus

Employee

Tom Fast

Advisor

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References